The presence of normal DAT availability on imaging can help to categorize subjects without evidence of dopamine deficiency from patients with reduced levels of baseline striatal DAT availability on PET or SPECT scanning, which should be considered as supportive rather than diagnostic of dopamine-deficient parkinsonism [83]. The gene discussed is SLC6A3; the disease is Parkinsonism.